Submitted by: Submitted by sankp
Views: 10
Words: 492
Pages: 2
Category: Business and Industry
Date Submitted: 04/04/2016 01:40 AM
Primary Sclerosing Cholangitis Market Share, Trends, Growth, Size, Analysis and Overview, Pipeline Review, H1 2016
Global Markets Direct's, 'Primary Sclerosing Cholangitis - Pipeline Review, H1 2016', provides an overview of the Primary Sclerosing Cholangitis pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Primary Sclerosing Cholangitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Primary Sclerosing Cholangitis and features dormant and discontinued projects.
Browse Detail Report With TOC @ http://www.radiantinsights.com/research/primary-sclerosing-cholangitis-pipeline-review-h1-2016
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information.
Table Of Content
Table of Contents 2
List of Tables 5
Buy a Sample copy of This Report @ http://www.radiantinsights.com/checkout/158887
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Primary Sclerosing Cholangitis Overview 7
Therapeutics Development 8
Pipeline Products for Primary Sclerosing...